NBC SECURITIES, INC.
Broker-DealerPosition in BHC — Bausch Health Companies Inc.
CIK 791540
BIRMINGHAM, AL
Position in BHC
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$493
-$317 QoQ
Shares Held
100
-33.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#210
of 220 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NBC SECURITIES, INC. holds $2,443,856 across 16 Drug Manufacturers - Specialty & Generic names. BHC ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
18,003 | $1,293,695 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
52,488 | $841,382 | |
| 3 | PRGO |
PERRIGO Co plc
|
15,094 | $156,826 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
8,000 | $80,000 | |
| 5 | ALKS |
Alkermes plc.
|
573 | $30,022 | |
| 6 | HROW |
Harrow, Inc.
|
412 | $17,497 | |
| 7 | VTRS |
Viatris Inc
|
557 | $8,845 | |
| 8 | HLN |
Haleon plc
|
882 | $8,229 |
All Filings in BHC
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $493 | 100 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $810 | 150 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $1,042 | 150 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $967 | 150 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1 | 200 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $1 | 200 | Shares | Sole | 2025-04-09 | |
| 2024-09-30 | $1 | 200 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1 | 200 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $2 | 275 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $2 | 275 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $3 | 425 | Shares | Sole | 2023-11-03 | |
| No filing history on record for this holder in this stock. | ||||||